FRT
50
2
ZTS
18
4
UA
41
2
F
56
4
AIZ
71
3
AMP
52
-11
WY
39
-9
FSLR
34
-6
ORCL
52
6
DVA
67
6
PBI
40
-3
LNC
45
2
IR
47
3
PEG
46
3
EQIX
43
-2
AES
45
4
JWN
60
-11
FTI
43
5
EW
23
-6
EA
62
3
FRT
50
2
ZTS
18
4
UA
41
2
F
56
4
AIZ
71
3
AMP
52
-11
WY
39
-9
FSLR
34
-6
ORCL
52
6
DVA
67
6
PBI
40
-3
LNC
45
2
IR
47
3
PEG
46
3
EQIX
43
-2
AES
45
4
JWN
60
-11
FTI
43
5
EW
23
-6
EA
62
3
Financhill
Back

Silence Therapeutics PLC 10K Form

Sell
45

SLNCF
Silence Therapeutics PLC

Last Price:
$1.47
Seasonality Move:
-17.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SLNCF News And Ratings

See the #1 stock for the next 7 days that we like better than SLNCF

SLNCF Financial Statistics

Sales & Book Value

Annual Sales: $43.3M
Cash Flow: $-26.1M
Price / Cash Flow: 0
Annual Sales: $0.95
Price / Book: 1.55

Profitability

EPS (TTM): -0.31140
Net Income (TTM): $-44M
Gross Margin: $31.4M
Return on Equity: -37.89%
Return on Assets: -21.31%

Silence Therapeutics PLC Earnings Forecast

Key Silence Therapeutics PLC Financial Ratios

  • The Gross Profit Margin over the past 7 years for SLNCF is 72.70%.
  • The Selling, General & Administrative Expenses for SLNCF have been equal to 62.15% of Gross Profit Margin.
  • The Research & Development expenses have been 156.93% of Revenue.
  • The Net Earning history of SLNCF is -104.74% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 16 years.

Silence Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Current Symbol: SLNCF
Website: silence-therapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 11.14
Quick Ratio: 10.27

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SLNCF Technical Analysis vs Fundamental Analysis

Sell
45
Silence Therapeutics PLC (SLNCF) is a Sell

Is Silence Therapeutics PLC a Buy or a Sell?